Pasithea Therapeutics (KTTA) Current Assets (2021 - 2024)
Historic Current Assets for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to $9.8 million.
- Pasithea Therapeutics' Current Assets fell 5292.16% to $9.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.8 million, marking a year-over-year decrease of 5292.16%. This contributed to the annual value of $16.7 million for FY2023, which is 5101.59% down from last year.
- Pasithea Therapeutics' Current Assets amounted to $9.8 million in Q3 2024, which was down 5292.16% from $8.6 million recorded in Q2 2024.
- Pasithea Therapeutics' Current Assets' 5-year high stood at $53.3 million during Q4 2021, with a 5-year trough of $8.6 million in Q2 2024.
- Over the past 4 years, Pasithea Therapeutics' median Current Assets value was $28.0 million (recorded in 2023), while the average stood at $29.3 million.
- Per our database at Business Quant, Pasithea Therapeutics' Current Assets skyrocketed by 11141.83% in 2022 and then crashed by 6917.47% in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Current Assets stood at $53.3 million in 2021, then plummeted by 36.07% to $34.1 million in 2022, then tumbled by 51.02% to $16.7 million in 2023, then crashed by 41.42% to $9.8 million in 2024.
- Its Current Assets stands at $9.8 million for Q3 2024, versus $8.6 million for Q2 2024 and $13.2 million for Q1 2024.